Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy
Description
CONCLUSION: IRT solutions contain high concentrations of anti-SARS-CoV-2 specific antibodies, which may prevent COVID-19; however, the efficacy can be influenced by variable virus-neutralizing activities against different viral strains. Therefore
